Guangdong Taiantang Pharmaceutical Co.,Ltd. Posted 129.1 Million Yuan Net Loss in First Half of 2022

Guangdong Taiantang Pharmaceutical Co.,Ltd. (广东太安堂药业股份有限公司) (002433.SZ) reported a net loss of 129.1 million yuan in the first half of 2022, reversing a net profit of 504 million yuan for the same period in the previous year.

Meanwhile, the company posted 509.7 million yuan in revenue, down 58.9% year-on-year.

At the end of the reporting period, it had 7.5 billion yuan in total assets and 3 billion yuan in total liabilities, with a liability-to-asset ratio of 40.3%.